These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34536931)
81. Novel indolylarylsulfone derivatives as covalent HIV-1 reverse transcriptase inhibitors specifically targeting the drug-resistant mutant Y181C. Gao P; Song S; Frutos-Beltrán E; Li W; Sun B; Kang D; Zou J; Zhang J; Pannecouque C; De Clercq E; Menéndez-Arias L; Zhan P; Liu X Bioorg Med Chem; 2021 Jan; 30():115927. PubMed ID: 33352387 [TBL] [Abstract][Full Text] [Related]
82. Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Boyer J; Arnoult E; Médebielle M; Guillemont J; Unge J; Jochmans D J Med Chem; 2011 Dec; 54(23):7974-85. PubMed ID: 22017513 [TBL] [Abstract][Full Text] [Related]
83. [Discovery and development of diarylpyrimidines (DAPYs) as next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)]. Tian XT; Xie L Yao Xue Xue Bao; 2010 Feb; 45(2):177-83. PubMed ID: 21351427 [TBL] [Abstract][Full Text] [Related]
84. Design, synthesis, and biological evaluation of piperidinyl-substituted [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potential anti-HIV-1 agents with reduced cytotoxicity. Huang B; Kang D; Tian Y; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X Chem Biol Drug Des; 2021 Jan; 97(1):67-76. PubMed ID: 32725669 [TBL] [Abstract][Full Text] [Related]
85. Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives. Ranise A; Spallarossa A; Cesarini S; Bondavalli F; Schenone S; Bruno O; Menozzi G; Fossa P; Mosti L; La Colla M; Sanna G; Murreddu M; Collu G; Busonera B; Marongiu ME; Pani A; La Colla P; Loddo R J Med Chem; 2005 Jun; 48(11):3858-73. PubMed ID: 15916438 [TBL] [Abstract][Full Text] [Related]
86. Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Ma XD; Zhang X; Dai HF; Yang SQ; Yang LM; Gu SX; Zheng YT; He QQ; Chen FE Bioorg Med Chem; 2011 Aug; 19(15):4601-7. PubMed ID: 21719299 [TBL] [Abstract][Full Text] [Related]
87. New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains. Nalli M; Armijos Rivera JI; Masci D; Coluccia A; Badia R; Riveira-Muñoz E; Brambilla A; Cinquina E; Turriziani O; Falasca F; Catalano M; Limatola C; Esté JA; Maga G; Silvestri R; Crespan E; La Regina G Eur J Med Chem; 2020 Dec; 208():112696. PubMed ID: 32883642 [TBL] [Abstract][Full Text] [Related]
88. Recent progress in HIV-1 inhibitors targeting the entrance channel of HIV-1 non-nucleoside reverse transcriptase inhibitor binding pocket. Gu SX; Xiao T; Zhu YY; Liu GY; Chen FE Eur J Med Chem; 2019 Jul; 174():277-291. PubMed ID: 31051402 [TBL] [Abstract][Full Text] [Related]
89. Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1. Chan JH; Freeman GA; Tidwell JH; Romines KR; Schaller LT; Cowan JR; Gonzales SS; Lowell GS; Andrews CW; Reynolds DJ; St Clair M; Hazen RJ; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Koszalka GW; Boone LR J Med Chem; 2004 Feb; 47(5):1175-82. PubMed ID: 14971897 [TBL] [Abstract][Full Text] [Related]
90. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach. Wang L; Tian Y; Chen W; Liu H; Zhan P; Li D; Liu H; De Clercq E; Pannecouque C; Liu X Eur J Med Chem; 2014 Oct; 85():293-303. PubMed ID: 25089812 [TBL] [Abstract][Full Text] [Related]
92. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Mai A; Sbardella G; Artico M; Ragno R; Massa S; Novellino E; Greco G; Lavecchia A; Musiu C; La Colla M; Murgioni C; La Colla P; Loddo R J Med Chem; 2001 Aug; 44(16):2544-54. PubMed ID: 11472208 [TBL] [Abstract][Full Text] [Related]
93. Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants. Kang D; Fang Z; Huang B; Lu X; Zhang H; Xu H; Huo Z; Zhou Z; Yu Z; Meng Q; Wu G; Ding X; Tian Y; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X J Med Chem; 2017 May; 60(10):4424-4443. PubMed ID: 28481112 [TBL] [Abstract][Full Text] [Related]
94. The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2. Lu X; Yang J; Kang D; Gao P; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X Bioorg Med Chem; 2018 May; 26(8):2051-2060. PubMed ID: 29559197 [TBL] [Abstract][Full Text] [Related]
95. Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors. Ma XD; He QQ; Zhang X; Yang SQ; Yang LM; Gu SX; Zheng YT; Chen FE; Dai HF Eur J Med Chem; 2012 Dec; 58():504-12. PubMed ID: 23164656 [TBL] [Abstract][Full Text] [Related]
96. Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor. Dousson C; Alexandre FR; Amador A; Bonaric S; Bot S; Caillet C; Convard T; da Costa D; Lioure MP; Roland A; Rosinovsky E; Maldonado S; Parsy C; Trochet C; Storer R; Stewart A; Wang J; Mayes BA; Musiu C; Poddesu B; Vargiu L; Liuzzi M; Moussa A; Jakubik J; Hubbard L; Seifer M; Standring D J Med Chem; 2016 Mar; 59(5):1891-8. PubMed ID: 26804933 [TBL] [Abstract][Full Text] [Related]
97. Structure-Based Optimization of 2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Exploiting the Tolerant Regions of the Non-Nucleoside Reverse Transcriptase Inhibitors' Binding Pocket. Zhao F; Zhang H; Xie M; Meng B; Liu N; Dun C; Qin Y; Gao S; De Clercq E; Pannecouque C; Tang YJ; Zhan P; Liu X; Kang D J Med Chem; 2023 Feb; 66(3):2102-2115. PubMed ID: 36700940 [TBL] [Abstract][Full Text] [Related]
98. Synthesis and biological properties of novel 2-aminopyrimidin-4(3H)-ones highly potent against HIV-1 mutant strains. Mai A; Artico M; Rotili D; Tarantino D; Clotet-Codina I; Armand-Ugón M; Ragno R; Simeoni S; Sbardella G; Nawrozkij MB; Samuele A; Maga G; Esté JA J Med Chem; 2007 Nov; 50(22):5412-24. PubMed ID: 17910429 [TBL] [Abstract][Full Text] [Related]
99. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs. Liu Z; Tian Y; Liu J; Huang B; Kang D; De Clercq E; Daelemans D; Pannecouque C; Zhan P; Liu X Eur J Med Chem; 2017 Nov; 140():383-391. PubMed ID: 28987601 [TBL] [Abstract][Full Text] [Related]
100. Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity. Manetti F; Esté JA; Clotet-Codina I; Armand-Ugón M; Maga G; Crespan E; Cancio R; Mugnaini C; Bernardini C; Togninelli A; Carmi C; Alongi M; Petricci E; Massa S; Corelli F; Botta M J Med Chem; 2005 Dec; 48(25):8000-8. PubMed ID: 16335924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]